You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drug Response Prediction (DRP)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-Resistant Prostate Cancer Patients Trial in Copenhagen (Irofulven, Prednisolone 10 mg)

Active, not recruiting
  • Metastatic Castration-Resistant Prostate Cancer Patients
  • Copenhagen, Denmark
    Rigshospitalet, Dept. Of Oncology
Feb 1, 2023

Ovarian Cancer Trial in Rome (Tumor biopsy)

Recruiting
  • Ovarian Cancer
  • Tumor biopsy
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 2, 2023

Computation Prediction of Drug Response Based on Omics Data

Enrolling by invitation
  • Breast Cancer
  • virtual anti-cancer drug
  • Beijing, Beijing, China
    Shuhua Zhao
Apr 25, 2023

Metastatic Breast Cancer Trial in Herlev, Vejle (PARP inhibitor 2X-121)

Active, not recruiting
  • Metastatic Breast Cancer
  • PARP inhibitor 2X-121
  • Herlev, Denmark
  • +1 more
Feb 1, 2023

Pharmacogenetic Testing and Chronic Pain

Not yet recruiting
  • Chronic Pain
  • Genetic test for drug response prediction
  • Ottawa, Ontario, Canada
    Canadian Forces Health Services Centre
Apr 28, 2022

Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)

Recruiting
  • Metastatic Breast Cancer
  • Ixabepilone Injection
  • Aalst, Belgium
  • +11 more
Nov 28, 2022

Drug Resistant Epilepsy Trial in Brno (Statistical model for the prediction of VNS efficacy)

Not yet recruiting
  • Drug Resistant Epilepsy
  • Statistical model for the prediction of VNS efficacy
  • Brno, Czechia
    University Hospital St. Anne´s Brno
Jun 22, 2021

Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)

Completed
  • Prostate Cancer Metastatic
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 6, 2022

Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)

Not yet recruiting
  • Fibrolamellar Hepatocellular Carcinoma
  • Baltimore, Maryland
    Johns Hopkins SKCCC
Aug 30, 2023

UsingEx Vivo Organ Culture on Fresh Human Tumour Samples From

Not yet recruiting
  • Advanced Cancer
  • Metastatic Cancer
    • (no location specified)
    Oct 21, 2020

    Relapsed/Refractory Multiple Myeloma Trial in Copenhagen (APO010)

    Terminated
    • Relapsed/Refractory Multiple Myeloma
    • Copenhagen, Denmark
      University Hospital of Copenhagen
    Jan 28, 2020

    Precise Prediction of Therapy Efficiency Trial (biopsy of tumor before treatment)

    Not yet recruiting
    • Precise Prediction of Therapy Efficiency
    • biopsy of tumor before treatment
    • (no location specified)
    Jan 31, 2023

    Breast Cancer Trial in Angers, Saint-Herblain (Biopsy, Blood samples, Questionnaires)

    Not yet recruiting
    • Breast Cancer
    • Biopsy
    • +2 more
    • Angers, France
    • +1 more
    Jul 31, 2023

    Gastric Cancer Response to Neoadjuvant Chemotherapy

    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • Neoadjuvant Chemotherapy
    • Beijing, China
    • +21 more
    Sep 6, 2023

    Pancreas Adenocarcinoma Trial (Treatment prediction PDT platform)

    Withdrawn
    • Pancreas Adenocarcinoma
    • Treatment prediction PDT platform
    • (no location specified)
    Feb 7, 2022

    Esophageal Squamous Cell Carcinoma Trial in Chongqing (Tislelizumab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Chongqing, Chongqing, China
      Army Medical Center of the People's Liberation Army
    May 26, 2023

    Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early

    Recruiting
    • Metastatic Breast Cancer in the Liver
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 23, 2022

    Prediction of Adolescents With MDD Response to ECT Via MRI

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Modified Electroconvulsive Therapy
    • Conventional pharmacotherapy
    • Chongqing, Province, China
      The First Affiliated Hospital of Chongqing Medical University
    May 26, 2023

    Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

    Recruiting
    • Muscle-Invasive Bladder Carcinoma
    • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Mar 11, 2023

    Drug-Related Problems : Focus on Age and Diabetes

    Completed
    • Adverse Drug Events
    • Detection of Adverse Drug Events or Drug-Related Problems
    • Montpellier, France
      Uhmontpellier
    Oct 22, 2021

    Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

    Recruiting
    • Aplastic Anemia
    • +2 more
    • Beijing, China
      Peking union medical college hospital
    Aug 20, 2023

    Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

    Recruiting
    • Esophagus Cancer
    • Xiamen, Fujian, China
      ShanghaiZhongshan
    Apr 8, 2023

    Ex Vivo Drug Response and Clinical Outcome in Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • Biological sample collection
    • Linz, Upper Austria, Austria
    • +2 more
    Sep 28, 2023

    Hypertension Trial in Aurora (drug, genetic, procedure)

    Terminated
    Has Results
    • Hypertension
    • metoprolol succinate
    • +2 more
    • Aurora, Colorado
      University of Colorado Denver; Emergency Department
    Aug 18, 2021

    Treatment (PROMPT) Response (PROMPT)

    Recruiting
    • Major Depressive Disorder
    • Münster, Germany
      Bernhard Baune
    Sep 12, 2022